Assessment of endothelial function by brachial artery flow mediated dilatation in microvascular disease

Cardiovascular Ultrasound

Volumn 9, Issue 1, 2011, Pages

  Naidu, Otikunta Adikesava ^a   Rajasekhar, Durgaprasad ^b   Latheef, S A A ^c  

^a OSMANIA GENERAL HOSPITAL   (India)

^b SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES   (India)

^c UNIVERSITY OF HYDERABAD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY DILATATION; ARTICLE; BODY MASS; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATATION; HUMAN; MALE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SYNDROME X; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; BLOOD FLOW VELOCITY; DILATATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

BLOOD FLOW VELOCITY; BRACHIAL ARTERY; DILATATION; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; VASODILATION;

EID: 84855346866     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-9-40     Document Type: Article

References (39)

1. Prevalence, pathogenesis, diagnosis and treatment of cardiac syndrome X. Crea F, http://www.escardio.org/communities/councils/ccp/e-journal/volume1/ Pages/Vol1-no15.aspx
2. Cardiac syndrome X: Current concepts. Singh M, Singh S, Arora R, Khosla S, Int J Cardiol 2010 142 113 119 10.1016/j.ijcard.2009.11.021 20138677
3. Inflammatory changes in small blood vessels in the endomyocardium of cardiac syndrome X in female patients with increased C-reactive protein. Zorc-Pleskovic R, Vraspir-Porenta O, Zorc M, Milutinovi A, Petrovic D, Folia Biol (Praha) 2008 54 30 32 (Pubitemid 351210803)
4. Cardiac syndrome X: Is it a treatable disease? Cay S, Tahir Durmaz T, Int J of Cardiol 2011 147 283 345 10.1016/j.ijcard.2009.08.018
5. Microvascular dysfunction in patients with cardiac syndrome X. Eugene B, Heart 2009 95 521 19164331
6. Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X. Di Monaco A, Bruno I, Sestito A, Lamendola P, Barone L, Bagnato A, Nerla R, Pisanello C, Giordano A, Lanza GA, Crea F, Heart 2009 95 7 550 554 19164330
7. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Kaski KC, Circulation 2004 109 568 572 10.1161/01.CIR.0000116601.58103.62 14769677 (Pubitemid 38198862)
8. Short duration of reactive hyperemia in the forearm of subjects with multiple cardiovascular risk factors. Ishibashi Y, Takahashi N, Shimada T, Sugamori T, Sakane T, Umeno T, Hirano Y, Oyake N, Murakami Y, Circ J 2006 70 115 123 10.1253/circj.70.115 16377935 (Pubitemid 43021244)
9. Quantitative assessment of coronary endothelial function. Moritaa K, Katohb C, Tamaki N, International Congress Series 2004 1264 132 135
10. Fundamentals of endothelial function for the clinical cardiologist. Verma S, Anderson TJ, Circulation 2002 105 546 549 10.1161/hc0502.104540 11827916 (Pubitemid 34123425)
11. Endothelial Function Testing as a Biomarker of Vascular Disease. Verma S, Buchanan MR, Anderson TJ, Circulation 2003 108 2054 2059 10.1161/01.CIR. 0000089191.72957.ED 14581384 (Pubitemid 37337577)
12. Reliable Endothelial Function Testing. At Our Fingertips? Celermajer DS, Circulation 2008 117 2428 2430 10.1161/CIRCULATIONAHA.108.775155 18474821 (Pubitemid 351670447)
13. Estimation of the concentration of low-density lipoproteins cholesterol in plasma without use of the ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 499 502 4337382
14. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Celermajer DS, Sorensen KE, Gooch VM, Miller, Sullivan ID, Lloyd JK, Deanfield JE, Spiegelhalter DJ, Lancet 1992 340 1111 5 10.1016/0140-6736(92)93147-F 1359209
15. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Zeiher AM, Drexler H, Wollschlaeger H, Just H, Circulation 1991 84 1984 1992 1934373
16. Rabelink. Endothelial Function and Dysfunction: Testing and Clinical Relevance. Deanfield JE, Halcox JP, Ton J, Circulation 2007 115 1285 1295 17353456 (Pubitemid 46594773)
17. Cyclooxygenase-2 blockade does not impair endothelial vasodilator function in healthy volunteers: randomized evaluation of rofecoxib versus naproxen on endotheliumdependent vasodilatation. Verma S, Raj SR, Shewchuk L, Mather KJ, Anderson TJ, Circulation 2001 104 2879 2882 10.1161/hc4901.101350 11739299 (Pubitemid 33139096)
18. Endothelial dysfunction and cardiovascular risk factors. Grover-Pa'ez Fernando, Zavalza-Go'mez Ana Bertha, Diab Res Clinical Pract 2009 84 1 10 10.1016/j.diabres.2008.12.013
19. Close relation of endothelial function in the human coronary and peripheral circulations. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP, J Am Coll Cardiol 1995 26 1235 1241 10.1016/0735-1097(95)00327-4 7594037
20. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A, Circulation 2000 101 948 954 10704159 (Pubitemid 30131694)
21. Prognostic value of coronary vascular endothelial dysfunction. Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA, Circulation 2002 106 653 658 10.1161/01.CIR.0000025404.78001.D8 12163423 (Pubitemid 34851922)
22. The association of elevated white blood cell count and C-reactive protein with endothelial dysfunction in cardiac syndrome X. Atmaca Y, Ozdol C, Turhan S, Vurgun K, Duzen V, Erol C, Acta Cardiol 2008 63 6 723 8 10.2143/AC.63.6. 2033389 19157167
23. Coronary artery calcium score assessed by a 64 multislice computed tomography and early indexes of functional and structural vascular remodeling in cardiac syndrome X patients. Mizia-Stec K, Haberka M, Mizia M, Chmiel A, Wierzbicka-Chmiel J, Skowerski M, Gasior Z, J Nucl Cardiol 2008 15 5 655 62 10.1016/j.nuclcard.2008.06.006 18761268
24. Significance of the lipid profile and endothelium-dependent vasodilatation in the pathogenesis of microvascular angina. Liu QM, Zhou SH, Qi SS, Zhao SP, Minghuib L, Cardiol J 2008 15 4 324 8 18698540
25. Arterial dysfunction in syndrome X: results of arterial reactivity and pulse wave propagation tests. Kidawa M, Krzeminska-Pakula M, Peruga JZ, Kasprzak JD, Heart 2003 89 4 422 6 10.1136/heart.89.4.422 12639871 (Pubitemid 36379416)
26. Cardiological syndrome X. Kidawa M, Krzemiska-Pakua M, Peruga JZ, Kasprzak JD, Trzos E, Non-invasive assessment of endothelial function and arterial compliance. Kardiol Pol 2003 59 11 385 96
27. Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms. Lekakis JP, Papamichael CM, Vemmos CN, Voutsas AA, Stamatelopoulos SF, Moulopoulos SD, J Am Coll Cardiol 1998 31 541 546 10.1016/S0735-1097(97)00542-1 9502632 (Pubitemid 28144118)
28. Cardiac syndrome X: Is it a treatable disease? Cay Serkan, Durmaz Tahir, Intl J Cardiol 2011 147 283 345 10.1016/j.ijcard.2009.08.018
29. Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X. Altun A, Yaprak M, Aktoz M, Vardar A, Betul UA, Ozbay G, Neurosci Lett 2002 327 143 5 10.1016/S0304-3940(02)00368-3 12098655 (Pubitemid 34722427)
30. Microvascular angina as a cause of chest pain with angiographically normal coronary arteries. Cannon RO, Epstein SE, Am J Cardiol 1988 62 1338 43
31. Therapeutic Development in Cardiac Syndrome X: A Need to Target the Underlying Pathophysiology. Lim TK, Choy AMJ, Khan F, Belch JJF, Struthers AD, Lang CC, Cardiovascular Therapeutics 2009 27 49 58 10.1111/j.1755-5922.2008. 00070.x 19207480
32. Structural and functional abnormality of systemic microvessels in cardiac syndrome X. Pasqui AL, Puccetti L, Di Renzo Bruni MF, Camarri A, Palazzuoli A, Biagi F, Servi M, Bischeri D, Auteri, Pastorelli AM, Nutrition, Metabolism & Cardiovascular Diseases 2005 15 56 64 10.1016/j.numecd.2004.05.001 22147677 (Pubitemid 40546035)
33. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. Rossi R, Chiurlia E, Nuzzo A, Cioni E, Origliani G, Modena MG, J Am Coll Cardiol 2004 44 1636 1640 10.1016/j.jacc.2004.07.027 15489096 (Pubitemid 39369796)
34. Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. Gkaliagkousi E, Douma S, Zamboulis C, Ferro A, J Hypertens 2009 27 2310 2320 10.1097/HJH.0b013e328330e89a 19838132
35. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Sander M, Chavoshan B, Victor RG, Hypertension 1999 33 937 942 10205227 (Pubitemid 29186388)
36. The impairment of flow-mediated vasodilation in obese men with visceral fat accumulation. Hashimoto M, Akishita M, Eto M, Kozaki K, Ako J, Sugimoto N, Yoshizumi M, Toba K, Ouchi Y, Int J Obes Relate Metab Discord 1998 22 5 477 484 10.1038/sj.ijo.0800620 (Pubitemid 28211977)
37. Obese and body fat distribution induce endothelial dysfunction by oxidative stress. Francesco P, Roberto C, Mafaldo C, Ventura G, Iacopino S, Sinopoli F, Mattioli PL, Diabetes 2001 50 159 165 10.2337/diabetes.50.1.159 11147782 (Pubitemid 32047995)
38. Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Pierce GL, Lesniewski LA, Lawson BR, Beske SD, Seals DR, Circulation 2009 119 9 1284 92 10.1161/CIRCULATIONAHA.108.804294 19237660
39. Mechanisms of endothelial dysfunction in obesity. Avogaro Angelo, de Kreutzenberg Saula Vigili, Clinica Chimica Acta 2005 360 9 26 10.1016/j.cccn.2005.04.020 (Pubitemid 41226497)